The China-based trial enrolled 398 patients who were randomised to the ivonescimab and Keytruda arms at a one-to-one ratio.

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

BioNTech stock has climbed 26% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics. A rival posted encouraging data on a drug that outperformed ...

In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by ...

At the Rajasthan Business Summit, ETHealthworld convened a discussion on "Reimagining Pharma and Healthcare: Innovations, ...

During HUAWEI CONNECT 2024, Huawei Cloud hosted a Summit themed 'One Step to Intelligence, One Leap to Excellence', gathering ...

Silence the Shame, is set to host a college empowerment summit to provide resources, support and inspiration to college ...

The state recognized the nonprofit organization for honoring its history and ongoing contributions to the community and the ...

Biologics License Application currently under review by U.S. FDA; PDUFA goal date of December 28, 2024WALTHAM, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc ...

Rayne Beau, a lost cat, managed to travel 800 miles back home after vanishing during a camping trip in Yellowstone National Park. Found exhausted in Roseville, California, he was reunited with his ...